Uneek Mehra's most recent trade in BridgeBio Oncology Therapeutics Inc. was a trade of 524 Common Stock done at an average price of $9.0 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc | Uneek Mehra | Former Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 01 Apr 2026 | 524 | 22,806 | - | 9.0 | 4,732 | Common Stock |
| BridgeBio Oncology Therapeutics Inc | Uneek Mehra | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Oncology Therapeutics Inc | Uneek Mehra | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 23,330 | 23,330 | - | 0 | Common Stock | |
| 4D Molecular Therapeutics Inc | Uneek Mehra | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Uneek Mehra | See Remarks | 11 Dec 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |